Last reviewed · How we verify
NCT04409899: UroCovid
The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department
trial testing Blood tests in COVID-19 in 300 participants. Status unknown.
30 June 2020
Quick facts
| Lead sponsor | Fundacio Puigvert |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 20 March 2020 |
| Primary completion | 30 June 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Blood tests — full drug profile →
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Urologic Diseases — all drugs for Urologic Diseases →
- Surgery--Complications — all drugs for Surgery--Complications →
- Epidemic Disease — all drugs for Epidemic Disease →
Sponsor
Fundacio Puigvert
Who can join
Eligibility, any sex, with COVID-19 or Urologic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since the outbreak of COVID-19 hit Spain in March 2020, most of the elective surgeries have been canceled everywhere. As soon as the epidemiology phase of the pandemic changed and the restrictions have been eased, different protocols have been put in place to screen patients for SARS-CoV-2 before surgery in order to reduce the spreading of the disease in hospitalized patients. To the best of the current state of knowledge, no recommendations or protocols have been established to guide surgeons in dealing with patients developing unspecific symptoms after surgeries, which could sign either of a post-op complication or COVID-19. The investigators have developed an enhanced pre and post-surgical protocol both to screen patients for COVID-19 before surgery and to promptly identify those patients suspicious for the viral infection during the post-op.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04409899
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood tests
Trials testing the same drug.
- NCT06698614 — MEMRI and Kidney Disease · recruiting
- NCT06630637 — Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study · NA · completed
- NCT06180278 — Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) · Phase 4 · active not recruiting
- NCT06156046 — Tolerance in Beekeepers · recruiting
- NCT05208099 — Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy · not yet recruiting
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Fundacio Puigvert trials
Trials by the same sponsor.
- NCT06866782 — European Registry of Next Generation Imaging in Advanced Prostate Cancer · recruiting
- NCT06928220 — The Impact of Manual Versus Mechanical Intestinal Suturing on the Incidence of Postoperative Complications Following Cys · NA · completed
- NCT04702347 — Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study · unknown
- NCT04712201 — En Bloc Bladder Tumor Resection: Prospective Randomized Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04409899 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacio Puigvert
- Last refreshed: 21 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04409899.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing